Thrombogenicity
From Wikipedia, the free encyclopedia
Thrombogenicity refers to the tendency of a material in contact with the blood to produce a thrombus, or clot. It not only refers to fixed thrombi but also to emboli, thrombi which have become detached and travel through the bloodstream. Thrombogenicity can also encompass events such as the activation of immune pathways and the complement system. All materials are considered to be thrombogenic[citation needed] with the exception of the normal state of endothelial cells which line blood vessels.[2] Certain medical implants appear non-thrombogenic due to high flow rates of blood past the implant, but in reality all are thrombogenic to a degree. Various surface treatments are available to minimize these thrombogenic effects.
![]() | This article needs more reliable medical references for verification or relies too heavily on primary sources. (November 2021) | ![]() |
IUPAC definition
Property of a material (or substance) that induces and/or promotes
the formation of a thrombus.[1]
A thrombogenic implant will eventually be covered by a fibrous capsule, the thickness of this capsule can be considered one measure of thrombogenicity, and if extreme can lead to the failure of the implant.
See also
References
Further reading
Wikiwand - on
Seamless Wikipedia browsing. On steroids.